Background: At present, the flexible endoscopic evaluation of swallowing (FEES) is one of the most commonly used methods for the objective assessment of swallowing. This multicenter trial prospectively collected data on the safety of FEES and also assessed the impact of this procedure on clinical dysphagia management. Methods: Patients were recruited in 23 hospitals in Germany and Switzerland from September 2014 to May 2017. Patient characteristics, professional affiliation of the FEES examiners (physicians or speech and language therapists), side-effects and cardiorespiratory parameters, severity of dysphagia and clinical consequences of FEES were documented. Results: 2401 patients, mean age 69.8 (14.6) years, 42.3% women, were included in the FEES-registry. The most common main diagnosis was stroke (61%), followed by Parkinson's disease (6.5%). FEES was well tolerated by patients. Complications were reported in 2% of examinations, were all self-limited and resolved without sequelae and showed no correlation to the endoscopist's previous experience. In more than 50% of investigations FEES led to changes of feeding strategies, in the majority of cases an upgrade of oral diet was possible. Discussion: This study confirmed that FEES, even when performed by less experienced clinicians is a safe and well tolerated procedure and significantly impacts on the patients' clinical course. Implementation of a FEES-service in different clinical settings may improve dysphagia care. Trial registration: ClinicalTrials.gov NCT03037762, registered January 31st 2017.
ZusammenfassungSialorrhoe, ein unkontrollierter, übermäßiger
Speichelfluss aus dem Mund und in den Schlund, tritt als Begleitsymptom bei
verschiedenen, v. a. neurologischen Erkrankungen im Kindes- und
Erwachsenenalter auf. Mit IncobotulinumtoxinA (Xeomin, IncoBoNT/A,
Merz Pharmaceuticals GmbH) steht seit 2019 ein zugelassenes Medikament
für die Behandlung der Sialorrhoe zur Verfügung.
Indikationsstellung, mögliche Therapieziele, Praxis der Behandlung und
Management in besonderen Behandlungssituationen bilden den Schwerpunkt dieser
konsentierten Praxis-Empfehlungen, die in interdisziplinärer
Zusammenarbeit erfahrener Anwender entwickelt wurden. Ziel ist, den Zugang zur
Therapie zu erleichtern und einen Beitrag zu einer qualifizierten
Botulinumtoxin-Therapie zu leisten.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.